Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Odds ratios with 95% confidence interval for death or myocardial infarction among troponin-negative and troponin-positive patients and for interaction of troponin status with treatment effect for Platelet Receptor inhibition for Ischemic Syndrome Management (PRISM), Chimeric c7E3 AntiPlatelet Therapy in Unstable REfractory angina (CAPTURE), Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network (PARAGON-B), and combined trials. Values to the left of 1.0 indicate a benefit of glycoprotein IIb/IIIa inhibition. TnT = troponin T. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the PARAGON-B Troponin T Substudy. Circulation 2001;103:2891–6. Reproduced with permission from Lippincott, Williams and Wilkins.
|
